Manuscript Submission

Authors must submit their papers to conference Email (icdici.conf@gmail.com) on or before the submission deadline mentioned in the conference homepage.

Submitted papers must be unpublished and not currently under review for any other publication.

 

The following are the instructions and guidelines to submit your manuscript to ICDICI 2022.

 

Formatting and Paper Template

• Papers submitted for review must clearly state:
• The purpose of the work
• To what extent it advances the state-of-the-art
• Specific results and their impact
• Use only Title Case for the paper title, i.e. capitalising all main words.
• There can be a maximum of 6 authors in a paper. If exceeds, the individual contribution made by each author should be mentioned. Do not use academic titles such as Dr., Professor, HoD, Director, etc. in your final paper.
• Follow the single-column format and the content should fit in the A4 Size
• The size of the paper is limited to 12-15 pages.
• Authors are requested to submit the paper by clearly stating the goals, methods and research findings of the chosen topic.
• The paper should be comprehensive, informative, and appealing to the readers.
• The manuscripts should be submitted in PDF format.

For more details on manuscript preparation, please visit:

https://www.springer.com/de/authors-editors/book-authors-editors/your-publication-journey/manuscript-preparation

 

Abstract Submission Template

Papers must be formatted using the Springer conference paper template. Paper must be submitted in English only.

 

Click here For Sample Springer Paper Format
Click here For Sample Springer Paper Format (LaTex Template)

 

Review Process

ICDICI 2022 will follow a peer-review process. All submitted papers will be reviewed based on quality, presentation and relevance to the conference theme. Papers that do not conform to the submission policies will be rejected without review. The most frequent cause of rejections of submitted papers is a lack of new results. Duplicated submissions to concurrent conferences must be avoided.

The decision of acceptance/rejection/revision will be communicated via Email to the corresponding author.

Note: Authors should register only when their work has been accepted.

 

Terms and Conditions:

• The paper has only been submitted once for ICDICI 2022. Duplicated submissions to concurrent conferences must be avoided.
• The most frequent cause of rejections of submitted papers is a lack of new results. Hence, the paper should report a novel research work.
• The Corresponding Author should provide his/her contact details to ICDICI for the purpose of the conference. It is the sole responsibility of the Corresponding Author to communicate with co-authors.
• Presenters may be recorded for live streaming and a recording of the presentation and a copy of the slides may be published online after the conference.
• The submission of a paper constitutes a formal commitment by the author[s] to present the work (if accepted) in the form, session and time assigned by the Programme Committee.

Publication Ethics and Conference Policy:

ICDICI reserves the right to retract a paper from proceedings after the conference if the paper is submitted in any other forum.

Papers are assessed on the basis that they are not plagiarized and have not been submitted to another conference at the same time (double submission). These are significant issues, and ICDICI will take appropriate action against any author who engages in either activity.

For more details refer: https://www.springer.com/gp/authors-editors/book-authors-editors/your-publication-journey/publishing-integrity